Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Amgen exits neuroscience R&D to focus on growth areas

Amgen exits neuroscience R&D to focus on growth areas GlaxoSmithKline, AstraZeneca, Merck &Co and Bristol-Myers Squibb are others that have decided the rewards of investing in this area are too remote, and the risks too great.

Merck CFO: we’re not only about Keytruda

Merck CFO: we’re not only about Keytruda But with rival immunotherapies from Bristol-Myers Squibb and AstraZeneca now angling for a slice of that market, multiple analysts asked how resilient Keytruda might be to competition from newer regimens, ... Bristol-Myers is in particular they're

AZ’s Imfinzi combo scores in front-line lung cancer

AZ’s Imfinzi combo scores in front-line lung cancer Hot on the heels of Bristol-Myers Squibb  announcing positive data for its Opdivo/Yervoy combo in non-small cell cancer, AstraZeneca has also unveiled its own phase 3 results in

New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare Roger Tomlins (pictured right), who joins Wilmington from Bristol-Myers Squibb, has worked in healthcare for over 16 years, in both the pharmaceutical industry and the NHS.

BMS’ Opdivo/Yervoy combo scores in front-line lung cancer

BMS’ Opdivo/Yervoy combo scores in front-line lung cancer Makes case for duo therapy in NSCLC patients. Bristol-Myers Squibb has announced positive results from its pivotal phase 3 CheckMate-9LA, making a case for its cancer drug combo in

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics